Johnson & Johnson (JNJ)vsQT Imaging Holdings, Inc. Common Stock (QTI)
JNJ
Johnson & Johnson
$255.88
-3.63%
HEALTHCARE · Cap: $615.36B
QTI
QT Imaging Holdings, Inc. Common Stock
$2.71
+2.26%
HEALTHCARE · Cap: $48.19M
Smart Verdict
WallStSmart Research — data-driven comparison
Johnson & Johnson generates 432124% more annual revenue ($97.93B vs $22.66M). JNJ leads profitability with a 21.5% profit margin vs -58.9%. JNJ earns a higher WallStSmart Score of 57/100 (C).
JNJ
Buy57
out of 100
Grade: C
QTI
Avoid27
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Mega-cap, among the largest globally
Every $100 of equity generates 25 in profit
Keeps 22 of every $100 in revenue as profit
Strong operational efficiency at 28.6%
Generating 3.4B in free cash flow
Revenue surging 133.4% year-over-year
Areas to Watch
Moderate valuation
Expensive relative to growth rate
Earnings declined 1.0%
Trading at 8.5x book value
0.0% earnings growth
Smaller company, higher risk/reward
Elevated debt levels
Comparative Analysis Report
WallStSmart ResearchBull Case : JNJ
The strongest argument for JNJ centers on Market Cap, Return on Equity, Profit Margin. Profitability is solid with margins at 21.5% and operating margin at 28.6%.
Bull Case : QTI
The strongest argument for QTI centers on Revenue Growth. Revenue growth of 133.4% demonstrates continued momentum.
Bear Case : JNJ
The primary concerns for JNJ are P/E Ratio, PEG Ratio, EPS Growth.
Bear Case : QTI
The primary concerns for QTI are Price/Book, EPS Growth, Market Cap. Debt-to-equity of 1.53 is elevated, increasing financial risk.
Key Dynamics to Monitor
JNJ profiles as a mature stock while QTI is a hypergrowth play — different risk/reward profiles.
JNJ carries more volatility with a beta of 0.23 — expect wider price swings.
QTI is growing revenue faster at 133.4% — sustainability is the question.
JNJ generates stronger free cash flow (3.4B), providing more financial flexibility.
Bottom Line
JNJ scores higher overall (57/100 vs 27/100), backed by strong 21.5% margins. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Johnson & Johnson
HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA
Johnson & Johnson (J&J) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods. Its common stock is a component of the Dow Jones Industrial Average and the company is ranked No. 36 on the 2021 Fortune 500 list of the largest United States corporations by total revenue. Johnson & Johnson is one of the world's most valuable companies, and is one of only two U.S.-based companies that has a prime credit rating of AAA, higher than that of the United States government.
Visit Website →QT Imaging Holdings, Inc. Common Stock
HEALTHCARE · MEDICAL DEVICES · USA
QT Imaging Holdings, Inc. engages in the manufacturing, research, and development of automated breast imaging system for producing high-resolution transmission ultrasound images. The company is headquartered in Novato, California.
Compare with Other DRUG MANUFACTURERS - GENERAL Stocks
Want to dig deeper into these stocks?